Zevra Therapeutics (ZVRA) Cash from Operations (2014 - 2026)
Zevra Therapeutics (ZVRA) reported Cash from Operations of $10.05 million for Q3 2026, up 113.4% from $4.71 million a year earlier but down 41.0% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Cash from Operations (2014 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Zevra Therapeutics' Cash from Operations came in at $38.74 million; for FY2025, it was -$1.6 million.
- By year, Cash from Operations came in at -$69.67 million in FY2024, -$33.54 million in FY2023, -$18.72 million in FY2022 and $10.44 million in FY2021.
- Five-year quarterly Cash from Operations spans a low of -$19.11 million in Q2 2024 and a high of $17.03 million in Q2 2026.
- Per Business Quant data, the three quarters before Q3 2026 came in at $17.03 million (Q2 2026), $6.14 million (Q1 2026) and $5.52 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 11.40 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 7.72 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.61 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 6.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.67 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.24 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.38 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 10.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.05 Mn |
| Jun 30, 2026 | 17.03 Mn |
| Mar 31, 2026 | 6.14 Mn |
| Dec 31, 2025 | 5.52 Mn |
| Sep 30, 2025 | 4.71 Mn |
| Jun 30, 2025 | -3.60 Mn |
| Mar 31, 2025 | -8.22 Mn |
| Dec 31, 2024 | -16.25 Mn |
| Sep 30, 2024 | -18.14 Mn |
| Jun 30, 2024 | -19.11 Mn |
| Mar 31, 2024 | -16.17 Mn |
| Dec 31, 2023 | -16.16 Mn |
| Sep 30, 2023 | -4.63 Mn |
| Jun 30, 2023 | -8.70 Mn |
| Mar 31, 2023 | -4.05 Mn |
| Dec 31, 2022 | -4.46 Mn |
| Sep 30, 2022 | -6.60 Mn |
| Jun 30, 2022 | -4.10 Mn |
| Mar 31, 2022 | -3.55 Mn |
| Dec 31, 2021 | -848,000.00 |
API Access
Zevra Therapeutics Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();